Company intelligence / Profile preview

ReVivo Medical

Loudonville, New York, United Statesrevivomedical.com ↗

Ownership: Private
Development stage: Phase 1

Overview

ReVivo Medical’s CEM-Cage® and CEM‑Plate® are currently being evaluated in an FDA-sanctioned first-in-human-use clinical trial to assess safety and efficacy for spinal surgery. As of September 2023, at least 46 patients have been implanted as part of ongoing studies. No published results from these trials are available yet.

Therapeutic areas: Neurology
Modalities: Device (Spinal implant)Implantable medical device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on ReVivo Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReVivo Medical.

Explore the full profile